tri-o-cresyl phosphate has been researched along with esmolol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckrich, B; Jahn, P; Mutschler, E; Palm, D; Schneidrowski, B; Schulte, B; Volz-Zang, C | 1 |
1 other study(ies) available for tri-o-cresyl phosphate and esmolol
| Article | Year |
|---|---|
Beta 1-adrenoceptor subtype selective antagonism of esmolol and its major metabolite in vitro and in man. Investigations using tricresylphosphate as red blood cell carboxylesterase inhibitor.
Topics: Adrenergic beta-1 Receptor Antagonists; Carboxylic Ester Hydrolases; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Kinetics; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-1; Tritolyl Phosphates | 1995 |